The United States Food and Drug Administration announced that Xanodyne Pharmaceuticals Inc. will remove medications containing propoxyphene from the market.
Recent reports claim propoxyphene puts some at risk of fatal heart rhythm abnormalities. This is considered a voluntary recall.
Studies are reported to show that propoxyphene may show electrical activity changes that may be seen on an electrocardiogram. The risks are considered high enough that this particular medication will not be allowed to remain on the market.
Prescription products such as Darvon and Darvocet contain propoxyphene. These will no longer be available in the United States. Patients taking prescription medications that contain propoxyphene should contact their physicians for instructions following this change.
No one is advised to stop medication without speaking with their doctor first. Physicians will decide which medication would be the best choice to replace propoxyphene.
Propoxyphene has been used without concern by many for decades. However, the information reviewed by the FDA has apparently influenced the decision to remove propoxyphene from the market. To view a video on YouTube.com about the removal of propoxyphene from the market, please follow this link.
Consumers with questions about the removal of propoxyphene may call 888-INFO-FDA. To view the FDA report, visit this site.